New preclinical data characterizing NE3107 mechanism of action featured in oral presentation
Phamacokinetic data from Phase 2a study supports potential co-administration of NE3107 with carbidopa/levodopa
Separate
Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune
Moderna Inc (NASDAQ:MRNA) said that data shows its omicron-tailored vaccines, mRNA-1273.214 and mRNA-1273.222, produced a higher antibody response against…